Australian-made drug results in a medical breakthrough

A new drug discovered in Melbourne to treat bone marrow cancer has been approved by US regulators and is expected to generate US $1 billion annually.

Clinical trials show that Momelotinib improves patients’ conditions and reduces treatment side effects.

Co-head of the Cancer Biology and Therapeutics Program at Peter MacCallum Cancer Centre, Professor Mark Dawson, told Mark Allen and Jimmy Bartel it “provides a greater quality of life”.

Press PLAY to hear more on the breakthrough drug